Windlas Biotech Limited (NSE:WINDLAS)
India · Delayed Price · Currency is INR 859.00
-0.90 (-0.10%)
Jul 31, 2026, 3:29 PM IST
Windlas Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 9,041 | 9,041 | 7,599 | 6,310 | 5,131 | 4,659 |
Revenue Growth | 18.98% | 18.98% | 20.43% | 22.97% | 10.12% | 8.96% |
Gross Profit Gross Profit Growth | 3,428 | 3,428 | 2,851 | 2,305 | 1,835 | 1,581 |
Operating Income Operating Income Growth | 739.99 | 739.99 | 664.94 | 647.28 | 478.7 | 402.76 |
Net Income Net Income Growth | 664.56 | 664.56 | 609.94 | 581.87 | 426.26 | 380.89 |
Earnings Per Share EPS Growth | 31.15 | 31.15 | 28.87 | 27.88 | 19.70 | 18.58 |
EPS Growth | 7.90% | 7.90% | 3.55% | 41.52% | 6.03% | 113.68% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 8,519 | 8,519 | 7,225 | 6,015 | 4,907 | 4,424 |
outside India outside India Growth | 458.38 | 458.38 | 326.32 | 273.91 | 198.43 | 209.35 |
Total Total Growth | 8,977 | 8,977 | 7,551 | 6,289 | 5,106 | 4,634 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,788 | 2,788 | 2,393 | 2,044 | 1,320 | 1,760 |
Total Debt Total Debt Growth | 352.42 | 352.42 | 325.97 | 36.41 | 49.93 | 66.37 |
Net Cash (Debt) Net Cash Growth | 2,436 | 2,436 | 2,067 | 2,007 | 1,270 | 1,694 |
Net Cash Growth | 17.85% | 17.85% | 2.97% | 58.08% | -25.04% | 673.25% |
Net Cash Per Share Net Cash Per Share Growth | 114.17 | 114.17 | 97.82 | 96.16 | 58.69 | 82.64 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,049 | 1,049 | 681.87 | 1,090 | 609.65 | 91.3 |
Capital Expenditures CapEx Growth | -676.64 | -676.64 | -521.94 | -376.84 | -708.9 | -148.04 |
Free Cash Flow Free Cash Flow Growth | 372.7 | 372.7 | 159.93 | 712.76 | -99.25 | -56.74 |
Free Cash Flow Growth | 133.04% | 133.04% | -77.56% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 37.92% | 37.92% | 37.52% | 36.54% | 35.77% | 33.92% |
Operating Margin | 8.19% | 8.19% | 8.75% | 10.26% | 9.33% | 8.64% |
Pretax Margin | 9.62% | 9.62% | 10.50% | 12.22% | 11.12% | 9.78% |
Profit Margin | 7.35% | 7.35% | 8.03% | 9.22% | 8.31% | 8.18% |
FCF Margin | 4.12% | 4.12% | 2.10% | 11.30% | -1.93% | -1.22% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 6.300 | 6.300 | 5.800 | 5.500 | 4.000 | 3.500 |
Dividend Per Share Growth | 8.62% | 8.62% | 5.46% | 37.50% | 14.29% | - |
Dividend Yield | 0.73% | 0.86% | 0.56% | 1.10% | 1.83% | 1.74% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 27.53 | 23.37 | 35.65 | 18.24 | 11.06 | 12.02 |
P/FCF Ratio | 47.49 | 41.67 | 135.98 | 14.89 | - | - |
PS Ratio | 1.96 | 1.72 | 2.86 | 1.68 | 0.92 | 0.98 |